| 1 |
Disveld IJM, Zoakman S, TLTA Jansen, et al. Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study [J]. Clin Rheumatol, 2019, 38(5): 1385-1391.
|
| 2 |
Kuo CF, Grainge MJ, Zhang W, et al. Global epidemiology of gout: prevalence, incidence and risk factors [J]. Nat Rev Rheumatol, 2015, 11(11): 649-662.
|
| 3 |
Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland china from 2000 to 2014: a systematic review and meta-analysis [J]. Biomed Res Int, 2015, 2015: 762820.
|
| 4 |
Liu H, Zhang XM, Wang YL, et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling [J]. J Nephrol, 2014, 27(6): 653-658.
|
| 5 |
Dalbeth N, Phipps-Green A, Frampton C, et al. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis [J]. Ann Rheum Dis, 2018, 77(7): 1048-1052.
|
| 6 |
Bădulescu M, Macovei L, Rezuş E. Acute gout attack with normal serum uric acid levels [J]. Rev Med Chir Soc Med Nat Iasi, 2014, 118(4): 942-945.
|
| 7 |
Kapetanovic R, Bokil NJ, Sweet MJ. Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: a ticking time bomb in ageing [J]. Ageing Res Rev, 2015, 24(Pt A): 40-53.
|
| 8 |
Szczurek W, Szyguła-Jurkiewicz B. Oxidative stress and inflammatory markers - the future of heart failure diagnostics? [J]. Kardiochir Torakochirurgia Pol, 2015, 12(2): 145-149.
|
| 9 |
Fujimura Y, Yamauchi Y, Murase T, et al. Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients [J]. PLoS One, 2017, 12(8): e0182699.
|
| 10 |
Shimizu T, Yoshihisa A, Kanno Y, et al. Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction [J]. Am J Physiol Heart Circ Physiol, 2015, 309(7): H1123-H1129.
|
| 11 |
Coiro S, Carluccio E, Biagioli P, et al. Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failure [J]. Nutr Metab Cardiovasc Dis, 2018, 28(4): 361-368.
|
| 12 |
Curtiss EI, Miller TR, Shapiro LS. Pulmonic regurgitation due to valvular tophi [J]. Circulation, 1983, 67(3): 699-701.
|
| 13 |
Giannopoulos G, Angelidis C, Deftereos S. Gout and arrhythmias: in search for causation beyond association [J]. Trends Cardiovasc Med, 2019, 29(1): 41-47.
|
| 14 |
Xu X, Du N, Wang R, et al. Hyperuricemia is independently associated with increased risk of atrial fibrillation: a meta-analysis of cohort studies [J]. Int J Cardiol, 2015, 184: 699-702.
|
| 15 |
Schlee S, Bollheimer LC, Bertsch T, et al. Crystal arthritides - gout and calcium pyrophosphate arthritis: Part 2: clinical features, diagnosis and differential diagnostics [J]. Z Gerontol Geriatr, 2018, 51(5): 579-584.
|
| 16 |
Arévalo-Lorido JC, Carretero-Gómez J, Pérez-Monteoliva NRR. Association between serum uric acid and carotid disease in patients with atherosclerotic acute ischemic stroke [J]. Vascular, 2019, 27(1): 19-26.
|
| 17 |
Leiba A, Vinker S, Dinour D, et al. Uric acid levels within the normal range predict increased risk of hypertension: a cohort study [J]. J Am Soc Hypertens, 2015, 9(8): 600-609.
|
| 18 |
Pan KL, Lin JC, Lin CL, et al. Impact of gout on left atrial function: a prospective speckle-tracking echocardiographic study [J]. PLoS One, 2014, 9(9): e108357.
|
| 19 |
Lin JC, Lin CL, Chen MC, et al. Gout, not hyperuricemia alone, impairs left ventricular diastolic function [J]. Arthritis Res Ther, 2015, 17: 323.
|
| 20 |
Gancheva RN, Kundurdjiev AI, Ivanova MG, et al. Ultrasonographic measurement of carotid artery resistive index and diastolic function of the heart in gout patients [J]. Rheumatol Int, 2015, 35(8): 1369-1375.
|
| 21 |
Zhang X, Lu Q, Zhang Z, et al. Value of three-dimensional speckle tracking echocardiography to assess left ventricular function in hyperuricemia patients [J]. Clin Rheumatol, 2018, 37(9): 2539-2545.
|
| 22 |
Rohani A, Chamanian S, Hosseinzade P, et al. A case of mitral valve tophus in a patient with severe gout tophaceous arthritis [J]. J Clin Imaging Sci, 2012, 2: 68.
|
| 23 |
Scalapino JN, Edwards WD, Steckelberg JM, et al. Mitral stenosis associated with valvular tophi [J]. Mayo Clin Proc, 1984, 59(7): 509-512.
|
| 24 |
Pan KL, Lin JC, Lin CL, et al. The effects of gout on left atrial volume remodelling: a prospective echocardiographic study [J]. Rheumatology (Oxford), 2014, 53(5): 867-874.
|
| 25 |
梁俊媚, 丁康, 徐艳燕, 等. 左心房容积追踪技术评价高尿酸血症患者左心房重构 [J]. 中国医学影像技术, 2016, 32(1): 57-62.
|
| 26 |
Ozturk D, Celık O, Akın F, et al. Usefulness of the uric acid and CHA2DS2-VASc score in prediction of left atrial thrombosis in patients with mitral stenosis and sinus rhythm [J]. Cardiol J, 2015, 22(3): 336-342.
|
| 27 |
Tang RB, Dong JZ, Yan XL, et al. Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation [J]. Can J Cardiol, 2014, 30(11): 1415-1421.
|
| 28 |
Gancheva R, Kundurdjiev A, Ivanova M, et al. Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography [J]. Rheumatol Int, 2017, 37(1): 121-130.
|
| 29 |
赵文, 闰志梅, 张桂俊, 等. 血管回声追踪技术评价高尿酸血症患者颈总动脉弹性功能的应用价值 [J]. 中华超声影像学杂志, 2014, 23(3): 211-213.
|
| 30 |
Krasnokutsky S, Romero AG, Bang D, et al. Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein [J]. Clin Rheumatol, 2018, 37(7): 1903-1911.
|
| 31 |
Gruszka K, Rajzer M, Drożdż T, et al. Selected matrix metalloproteinases activity and hypertension-mediated organ damage in relation to uric acid serum level [J]. Cardiol J, 2019 Apr 17. DOI: 10.5603/CJ.a2019.0033.Onlineaheadofprint. |
| 32 |
Wang Q, Tan K, Xia H, et al. The further negative effect of hyperuricemia on left ventricular structure and function in patients with type 2 diabetes mellitus: a transthoracic 3D speckle tracking imaging study [J]. Metab Syndr Relat Disord, 2019, 17(9): 436-443.
|
| 33 |
Basar C, Besli F, Ozhan H, et al. Assessment of myocardial performance index in hypertensive patients with or without hyperuricaemia [J]. Kardiol Pol, 2016, 74(11): 1339-1345.
|
| 34 |
Basar C, Besli F, Turker Y, et al. Total atrial conduction time evaluated with tissue Doppler imaging increases in hypertensive patients with hyperuricemia [J]. Blood Press Monit, 2015, 20(5): 249-253.
|
| 35 |
张晓洁, 张卓君, 孔秀芳, 等. 三维斑点追踪心脏超声评价高尿酸血症患者左心室收缩功能早期改变 [J]. 中华风湿病学杂志, 2017, 2(10): 663-666.
|
| 36 |
Fang X, Pan C, Chen Y, et al. Assessment of subclinical left ventricular changes in essential hypertensive patients with hyperuricemia: a three-dimensional speckle-tracking echocardiography study [J]. Clin Exp Hypertens, 2017, 39(1): 93-99.
|
| 37 |
Xin W, Mi S, Lin Z. Allopurinol therapy improves vascular endothelial functien in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials [J]. Cardiovasc Ther, 2016, 34(6): 441-449.
|
| 38 |
Castillo-Martínez D, Marroquín-Fabián E, Lozada-Navarro AC, et al. Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study [J]. Lupus, 2016, 25(1): 61-66.
|
| 39 |
Erdogan D, Tayyar S, Uysal BA, et al. Effects of allopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy [J]. Can J Cardiol, 2012, 28(6) :721-727.
|